Skip to content
2000
Volume 2, Issue 2
  • ISSN: 2666-1217
  • E-ISSN: 2666-1225

Abstract

Background

The diversity of components in arthropod venoms constitute a rich source of bioactive molecules. Brazil is the most biodiverse country in the world, comprising 15 to 20% of the total catalogued species, with approximately 103,870 animal species including arthropods. Although many articles mention the biotechnological potential of these venoms and toxins, only a few studies compile the patented uses of these molecules.

Objective

This review describes the knowledge about the molecular mechanism of venoms and toxins with biotechnological potential, and lists the patents deposited up to 2021 related to the main medical relevant arthropods in Brazil including the orders Araneae (spider genus , , ), Scorpiones (scorpion genus ), Lepidoptera (caterpillar genus ), and Hymenoptera.

Methods

The international patent search engine “Espacenet” and the “Brazilian patent office” were used to search the patents described in this article.

Results

Up to date, 34 patents have been filled involving these Brazilian arthropods' venoms or toxins. Most of them (20) claimed biotechnological inventions with spider toxins, mainly from the genus . Only seven inventions involved venom or toxins from scorpions, one from a bee, three from wasps, and three from caterpillars.

Conclusions

Brazil is one of the main references in venoms and toxins’ studies; however, the limited number of deposited patents related to this area by Brazilian researchers do not reflect their pioneer position in this field. On the other hand, patents were well described and made with purified toxins, rather than with the whole venom. Nevertheless, the vast publication record of venom and toxin characterization that leads to a better understanding of their molecular mechanisms paves the way for turning these promising molecules into possible products.

Loading

Article metrics loading...

/content/journals/vat/10.2174/2666121702666220523143235
2022-08-01
2025-03-01
Loading full text...

Full text loading...

References

  1. KingG.F. Tying pest insects in knots: The deployment of spider-venom-derived knottins as bioinsecticides.Pest Manag. Sci.20197592437244510.1002/ps.5452 31025461
    [Google Scholar]
  2. The convention on biological diversity Convention on Biological Diversity2021Available from: https://www.cbd.int/
  3. Di FabioJ.L. Cortés CastilloM.Á. GriffithsE. Landscape of research, production, and regulation in venoms and antivenoms: A bibliometric analysis.Rev. Panam. Salud Publica202145110.26633/RPSP.2021.55
    [Google Scholar]
  4. Instituto Nacional de Propriedade IntelectualINPI.2021Available from: https://gru.inpi.gov.br/pePI/
    [Google Scholar]
  5. Espacenet – patent search 2021https://worldwide.espacenet.com/
  6. Rezende JúniorL. CordeiroM.N. OliveiraE.B. DinizC.R. Isolation of neurotoxic peptides from the venom of the ‘armed’ spider Phoneutria nigriventer.Toxicon199129101225123310.1016/0041‑0101(91)90195‑W 1801316
    [Google Scholar]
  7. FigueiredoS.G. GarciaM.E. ValentimA.C. CordeiroM.N. DinizC.R. RichardsonM. Purification and amino acid sequence of the insecticidal neurotoxin Tx4(6-1) from the venom of the ‘armed’ spider Phoneutria nigriventer (Keys).Toxicon1995331839310.1016/0041‑0101(94)00130‑Z 7778132
    [Google Scholar]
  8. de LimaM.E. FigueiredoS.G. MatavelA. NunesK.P. da SilvaC.N. De Marco AlmeidaF. Phoneutria nigriventer Venom and Toxins: A Review. Spider Venoms.Springer Netherlands: Dordrecht2016719910.1007/978‑94‑007‑6389‑0_6
    [Google Scholar]
  9. Martin-MoutotN. MansuelleP. AlcarazG. Phoneutria nigriventer toxin 1: A novel, state-dependent inhibitor of neuronal sodium channels that interacts with micro conotoxin binding sites.Mol. Pharmacol.20066961931193710.1124/mol.105.021147 16505156
    [Google Scholar]
  10. SilvaA.O. PeigneurS. DinizM.R.V. TytgatJ. BeirãoP.S.L. Inhibitory effect of the recombinant Phoneutria nigriventer Tx1 toxin on voltage-gated sodium channels.Biochimie201294122756276310.1016/j.biochi.2012.08.016 22968173
    [Google Scholar]
  11. PeigneurS. de LimaM.E. TytgatJ. Phoneutria nigriventer venom: A pharmacological treasure.Toxicon20181519611010.1016/j.toxicon.2018.07.008 30003916
    [Google Scholar]
  12. CordeiroM.N. DinizC.R. ValentimA.C. von EickstedtV.R. GilroyJ. RichardsonM. The purification and amino acid sequences of four Tx2 neurotoxins from the venom of the Brazilian ‘armed’ spider Phoneutria nigriventer (Keys).FEBS Lett.1992310215315610.1016/0014‑5793(92)81318‑G 1397265
    [Google Scholar]
  13. PeigneurS. PaivaA.L.B. CordeiroM.N. Phoneutria nigriventer spider toxin PnTx2-1 (δ-Ctenitoxin-Pn1a) is a modulator of sodium channel gating.Toxins (Basel)201810933710.3390/toxins10090337 30134593
    [Google Scholar]
  14. MatavelA. FleuryC. OliveiraL.C. Structure and activity analysis of two spider toxins that alter sodium channel inactivation kinetics.Biochemistry200948143078308810.1021/bi802158p 19231838
    [Google Scholar]
  15. NunesK.P. Costa-GonçalvesA. LanzaL.F. Tx2-6 toxin of the Phoneutria nigriventer spider potentiates rat erectile function.Toxicon20085171197120610.1016/j.toxicon.2008.02.010 18397797
    [Google Scholar]
  16. NunesK.P. WynneB.M. CordeiroM.N. Increased cavernosal relaxation by Phoneutria nigriventer toxin, PnTx2-6, via activation at NO/cGMP signaling.Int. J. Impot. Res.2012242697610.1038/ijir.2011.47 21975567
    [Google Scholar]
  17. SinisterraRD Método para a potencialização da função erétil através do uso das composições farmacêuticas de toxina tx2-6 da aranha Phoneutria nigriventer.BRPI0800596A22009
    [Google Scholar]
  18. SilvaCN AlmeidaFM LomeoRS Synthetic Pntx(19) peptide, pharmaceutical compositions and use.WO2014028997A12014
    [Google Scholar]
  19. SilvaC.N. NunesK.P. TorresF.S. PnPP-19, a synthetic and nontoxic peptide designed from a Phoneutria nigriventer toxin, potentiates erectile function via NO/cGMP.J. Urol.201519451481149010.1016/j.juro.2015.06.081 26119670
    [Google Scholar]
  20. FreitasA.C.N. PachecoD.F. MachadoM.F.M. CarmonaA.K. DuarteI.D.G. de LimaM.E. PnPP-19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidase.Br. J. Pharmacol.201617391491150110.1111/bph.13448 26947933
    [Google Scholar]
  21. da Fonseca PachecoD. FreitasA.C.N. PimentaA.M.C. DuarteI.D.G. de LimaM.E. A spider derived peptide, PnPP-19, induces central antinociception mediated by opioid and cannabinoid systems.J. Venom. Anim. Toxins Incl. Trop. Dis.20162213410.1186/s40409‑016‑0091‑6 28031732
    [Google Scholar]
  22. FreitasA.C.N. PeigneurS. MacedoF.H.P. The peptide PnPP-19, a spider toxin derivative, activates μ-opioid receptors and modulates calcium channels.Toxins (Basel)2018101E4310.3390/toxins10010043 29342943
    [Google Scholar]
  23. da SilvaC.N. DouradoL.F.N. de LimaM.E. da Silva Cunha-JrA. PnPP-19 peptide as a novel drug candidate for topical glaucoma therapy through nitric oxide release.Transl. Vis. Sci. Technol.2020983310.1167/tvst.9.8.33 32855879
    [Google Scholar]
  24. Cunha-JrAS De LimaME SilvaSCN NunesDLF BorgesDSPV LacativaPGS Method and use of PnPP-19 for preventing and treating eye diseases.US2021060125A12021
  25. ChoiJN ChoiTW KimTH Sv82 polypeptide and cosmetic composition for improving wrinkle and maintaining elasticity of skin comprising Sv82 polypeptide as effective component.KR101613302B12016
    [Google Scholar]
  26. ChoiJN ChoiTW JeongTH Thermostable human epidermal growth factor-spider venom fusion protein with increased skin cell proliferation and cosmetic composition for improving wrinkle and maintaining elasticity of skin comprising the same as effective component.KR101636851B12016
    [Google Scholar]
  27. ChoiKH KimSR KimSW YuJH Baculovirus expressing recombinant spider toxin protein or trasngenic silk worm manufactured therefrom.KR101922425B12018
    [Google Scholar]
  28. de LimaM.E. FigueiredoS.G. MatavelA. Phoneutria nigriventer venom and toxins: A review. Spider Venoms.Springer Netherlands: Dordrecht2016719910.1007/978‑94‑007‑6389‑0_6
    [Google Scholar]
  29. KushmerickC. KalapothakisE. BeirãoP.S. Phoneutria nigriventer toxin Tx3-1 blocks A-type K+ currents controlling Ca2+ oscillation frequency in GH3 cells.J. Neurochem.19997241472148110.1046/j.1471‑4159.1999.721472.x 10098851
    [Google Scholar]
  30. RigoF.K. RossatoM.F. TrevisanG. PhKv a toxin isolated from the spider venom induces antinociception by inhibition of cholinesterase activating cholinergic system.Scand. J. Pain201717203210 29107209
    [Google Scholar]
  31. AlmeidaA.P. AndradeA.B. FerreiraA.J. Antiarrhythmogenic effects of a neurotoxin from the spider Phoneutria nigriventer.Toxicon201157221722410.1016/j.toxicon.2010.11.013 21115025
    [Google Scholar]
  32. GomezMV PradoMA PradoVF , Pinheiro AC do N, Richardson M, Almeida AP. Toxina PhKv, cDNA do gene da toxina PhKv, composições farmacêuticas contendo a toxina PhKv, processo para sua obtenção, processo para obtenção do Cdna, e produto. BRPI0702734A22009
    [Google Scholar]
  33. LeãoR.M. CruzJ.S. DinizC.R. CordeiroM.N. BeirãoP.S. Inhibition of neuronal high-voltage activated calcium channels by the omega-Phoneutria nigriventer Tx3-3 peptide toxin.Neuropharmacology200039101756176710.1016/S0028‑3908(99)00267‑1 10884557
    [Google Scholar]
  34. DalmolinG.D. BannisterK. GonçalvesL. Effect of the spider toxin Tx3-3 on spinal processing of sensory information in naive and neuropathic rats: An in vivo electrophysiological study.Pain Rep.201724e61010.1097/PR9.0000000000000610 29392225
    [Google Scholar]
  35. Dos SantosR.G. Van RenterghemC. Martin-MoutotN. Phoneutria nigriventer ω-phonetoxin IIA blocks the Cav2 family of calcium channels and interacts with ω-conotoxin-binding sites.J. Biol. Chem.200227716138561386210.1074/jbc.M112348200 11827974
    [Google Scholar]
  36. AgostiniR.M. do Nascimento PinheiroA.C. BindaN.S. Phoneutria spider toxins block ischemia-induced glutamate release and neuronal death of cell layers of the retina.Retina20113171392139910.1097/IAE.0b013e318205b249 21394062
    [Google Scholar]
  37. BindaN.S. CarayonC.P. AgostiniR.M. PhTx3-4, a spider toxin calcium channel blocker, reduces NMDA-induced injury of the retina.Toxins (Basel)2016837010.3390/toxins8030070 26978403
    [Google Scholar]
  38. PinheiroA.C. da SilvaA.J. PradoM.A. Phoneutria spider toxins block ischemia-induced glutamate release, neuronal death, and loss of neurotransmission in hippocampus.Hippocampus200919111123112910.1002/hipo.20580 19370546
    [Google Scholar]
  39. FonsecaCG ReisHJD GomesMV Peptídeo recombinante da toxina pha1a, composições farmacêuticas contendo pha1a, e uso.BRPI1013470A22015
    [Google Scholar]
  40. EvansM.S. ChengX. JeffryJ.A. DisneyK.E. PremkumarL.S. Sumatriptan inhibits TRPV1 channels in trigeminal neurons.Headache201252577378410.1111/j.1526‑4610.2011.02053.x 22289052
    [Google Scholar]
  41. NagemRAP GomezMV PereiraEMR Sequência de nucleotídeos, proteína recombinante, composições farmacêuticas e usos. BR102018010621A22020
    [Google Scholar]
  42. VermaD. GuptaY.K. ParasharA. RayS.B. Differential expression of L- and N-type voltage-sensitive calcium channels in the spinal cord of morphine+nimodipine treated rats.Brain Res.2009124912813410.1016/j.brainres.2008.10.038 18996361
    [Google Scholar]
  43. OliveiraS.M. SilvaC.R. TrevisanG. Antinociceptive effect of a novel armed spider peptide Tx3-5 in pathological pain models in mice.Pflugers Arch.2016468588189410.1007/s00424‑016‑1801‑1 26898377
    [Google Scholar]
  44. SouzaA.H. FerreiraJ. CordeiroM.D.N. Analgesic effect in rodents of native and recombinant Ph alpha 1beta toxin, a high-voltage-activated calcium channel blocker isolated from armed spider venom.Pain2008140111512610.1016/j.pain.2008.07.014 18774645
    [Google Scholar]
  45. VieiraL.B. KushmerickC. HildebrandM.E. Inhibition of high voltage-activated calcium channels by spider toxin PnTx3-6.J. Pharmacol. Exp. Ther.200531431370137710.1124/jpet.105.087023 15933156
    [Google Scholar]
  46. PalharesM.R. SilvaJ.F. RezendeM.J.S. Synergistic antinociceptive effect of a calcium channel blocker and a TRPV1 blocker in an acute pain model in mice.Life Sci.201718212212810.1016/j.lfs.2017.06.018 28629730
    [Google Scholar]
  47. GomezMV MaximoPMA PradoVF PHa1B toxin, cDNA of PHa1 B toxins gene, pharmaceutical composition containing PHa1B toxin, processes for their obtention and product.WO2008061329A22008
    [Google Scholar]
  48. TonelloR. RigoF. GewehrC. Action of Phα1β a peptide from the venom of the spider Phoneutria nigriventer, on the analgesic and adverse effects caused by morphine in mice.J. Pain201415661963110.1016/j.jpain.2014.02.007 24607814
    [Google Scholar]
  49. TonelloR. FusiC. MaterazziS. The peptide Phα1β from spider venom, acts as a TRPA1 channel antagonist with antinociceptive effects in mice.Br. J. Pharmacol.20171741576910.1111/bph.13652 27759880
    [Google Scholar]
  50. SilvaR.B.M. GreggioS. VenturinG.T. da CostaJ.C. GomezM.V. CamposM.M. Beneficial effects of the calcium channel blocker CTK 01512-2 in a mouse model of multiple sclerosis.Mol. Neurobiol.201855129307932710.1007/s12035‑018‑1049‑1 29667130
    [Google Scholar]
  51. Barreto Dos SantosN BonfantiAP Rocha-E-SilvaTAAD Venom of the Phoneutria nigriventer spider alters the cell cycle, via bility, and migration of cancer cells.J. Cell. Physiol.201923421398141510.1002/jcp.26935 30078202
    [Google Scholar]
  52. BonfantiA.P. BarretoN. MunhozJ. Spider venom administration impairs glioblastoma growth and modulates immune response in a non-clinical model.Sci. Rep.2020101587610.1038/s41598‑020‑62620‑9 32246025
    [Google Scholar]
  53. NicolettiN.F. ErigT.C. ZaninR.F. Pre-clinical evaluation of voltage-gated calcium channel blockers derived from the spider P. nigriventer in glioma progression.Toxicon2017129586710.1016/j.toxicon.2017.02.001 28202361
    [Google Scholar]
  54. de FigueiredoS.G. de LimaM.E. Nascimento CordeiroM. Purification and amino acid sequence of a highly insecticidal toxin from the venom of the brazilian spider Phoneutria nigriventer which inhibits NMDA-evoked currents in rat hippocampal neurones.Toxicon2001392-330931710.1016/S0041‑0101(00)00129‑X 10978749
    [Google Scholar]
  55. SilvaF.R. BatistaE.M.L. GomezM.V. The Phoneutria nigriventer spider toxin, PnTx4-5-5, promotes neuronal survival by blocking NMDA receptors.Toxicon2016112162110.1016/j.toxicon.2016.01.056 26802625
    [Google Scholar]
  56. OliveiraC.F.B. AlvesD.P. EmerichB.L. Antinociceptive effect of PnTx4(5-5), a peptide from Phoneutria nigriventer spider venom, in rat models and the involvement of glutamatergic system.J. Venom. Anim. Toxins Incl. Trop. Dis.201925e2019002210.1590/1678‑9199‑jvatitd‑2019‑0022 31467512
    [Google Scholar]
  57. Perez-GarciaMEDL PaivaALB OliveiraCFBD Composição farmacêutica com atividade analgésica à base de uma toxina de aranha, proteína de fusão, vetor de expressão dessa toxina e usos. BR102014031481A22016
  58. PaivaA.L.B. MatavelA. PeigneurS. Differential effects of the recombinant toxin PnTx4(5-5) from the spider Phoneutria nigriventer on mammalian and insect sodium channels.Biochimie201612132633510.1016/j.biochi.2015.12.019 26747232
    [Google Scholar]
  59. EmerichBL FerreiraRC CordeiroMN δ-Ctenitoxin-Pn1a, a peptide from Phoneutria nigriventer spider venom, shows antinociceptive effect involving opioid and cannabinoid systems, in rats.Toxins (Basel)20168410610.3390/toxins8040106 27077886
    [Google Scholar]
  60. EmerichB.L. FerreiraR.C.M. Machado-de-AvilaR.A. ResendeJ.M. DuarteI.D.G. de LimaM.E. PnAn13, an antinociceptive synthetic peptide inspired in the Phoneutria nigriventer toxin PnTx4(6-1) (δ-Ctenitoxin-Pn1a).Toxicon X2020710004510.1016/j.toxcx.2020.100045 32875290
    [Google Scholar]
  61. Cunha-JrA da S Perez-Garcia MEDL, Silva FR, Silva CN, Dourado LFN, Toledo CR. Peptídeos sintéticos neuroprotetores e analgésicos, formulações farmacêuticas e usos.BR1020180750615A2
    [Google Scholar]
  62. de LimaM.E. StankiewiczM. HamonA. The toxin Tx4(6-1) from the spider Phoneutria nigriventer slows down Na(+) current inactivation in insect CNS via binding to receptor site 3.J. Insect Physiol.2002481536110.1016/S0022‑1910(01)00143‑3 12770132
    [Google Scholar]
  63. JiangY LiH XiaY Production method of toxin Tx4 (6-1) labelfree recombinant protein.CN106754945A2017
    [Google Scholar]
  64. AvisarD ShaniZ SteinH Pest-resistant plants containing a combination of a spider toxin and a chitinase.US2013097731A12013
  65. DinizM.R.V. PaivaA.L.B. Guerra-DuarteC. An overview of Phoneutria nigriventer spider venom using combined transcriptomic and proteomic approaches.PLoS One2018138e020062810.1371/journal.pone.0200628 30067761
    [Google Scholar]
  66. PaivaA.L.B. MudaduM.A. PereiraE.H.T. MarriC.A. Guerra-DuarteC. DinizM.R.V. Transcriptome analysis of the spider Phoneutria pertyi venom glands reveals novel venom components for the genus Phoneutria.Toxicon2019163596910.1016/j.toxicon.2019.03.014 30902682
    [Google Scholar]
  67. LorenziniD.M. da SilvaP.I.Jr FogaçaA.C. BuletP. DaffreS. Acanthoscurrin: A novel glycine-rich antimicrobial peptide constitutively expressed in the hemocytes of the spider Acanthoscurria gomesiana.Dev. Comp. Immunol.200327978179110.1016/S0145‑305X(03)00058‑2 12818635
    [Google Scholar]
  68. BaumannT. KämpferU. SchürchS. Ctenidins: Antimicrobial glycine-rich peptides from the hemocytes of the spider Cupiennius salei.Cell Mol Life Sci CMLS201067162787279810.1007/s00018‑010‑0364‑0 20369272
    [Google Scholar]
  69. GremskiL.H. da JustaH.C. da SilvaT.P. Forty years of the description of brown spider venom phospholipases-D.Toxins (Basel)202012316410.3390/toxins12030164 32155765
    [Google Scholar]
  70. Karim-SilvaS. Becker-FincoA. JiacominiI.G. Loxoscelism: Advances and challenges in the design of antibody fragments with therapeutic potential.Toxins (Basel)202012425610.3390/toxins12040256 32316084
    [Google Scholar]
  71. AndradeRMGD AzevedoIDLMJ GuidolinR Processo de obtenção de soro eqüino anti-loxoscélico.BRPI0404765A2007
  72. AlvarengaLM FigueiredoLFM LopesCD Proteína quimérica recombinante, composição imunogênica, processo de obtenção, uso para a produção de vacinas e soros contra a picada das aranhas loxosceles spp.BR102013026570A22016
  73. KalapothakisE. Proteìna e sequência de dna da aranha loxosceles intermedia para produção de uma proteìna recombinante e sua utilização no processo de produção de soro e vacina especificada contra a picanha de aranhas do gênero loxosceles. BR0202596A2004
  74. LopesDL OlórteguiCDC NguyenC Composição imunogênica vacinal e terapêutica contra picada de aranha marrom.BRPI1103104A22017
    [Google Scholar]
  75. ChaimOM FerrerVP GremskiLH Proteína identificada como hialuronidase presente no veneno de loxosceles intermedia, clonada e expressa de forma recombinante em sistema de expressão heterólogo.BRPI1107350A22015
    [Google Scholar]
  76. ChaimO.M. Trevisan-SilvaD. Chaves-MoreiraD. Brown spider (Loxosceles genus) venom toxins: Tools for biological purposes.Toxins (Basel)20113330934410.3390/toxins3030309 22069711
    [Google Scholar]
  77. Senff-RibeiroA. Henrique da SilvaP. ChaimO.M. Biotechnological applications of brown spider (Loxosceles genus) venom toxins.Biotechnol. Adv.200826321021810.1016/j.biotechadv.2007.12.003 18207690
    [Google Scholar]
  78. Chaves-MoreiraD. MatsubaraF.H. Schemczssen-GraeffZ. Brown spider (Loxosceles) venom toxins as potential biotools for the development of novel therapeutics.Toxins (Basel)2019116E35510.3390/toxins11060355 31248109
    [Google Scholar]
  79. McGlassonD.L. BabcockJ.L. BergL. TriplettD.A. ARACHnase. An evaluation of a positive control for platelet neutralization procedure testing with seven commercial activated partial thromboplastin time reagents.Am. J. Clin. Pathol.1993100557657810.1093/ajcp/100.5.576 8249897
    [Google Scholar]
  80. de CastroC.S. SilvestreF.G. AraújoS.C. Identification and molecular cloning of insecticidal toxins from the venom of the brown spider Loxosceles intermedia.Toxicon200444327328010.1016/j.toxicon.2004.05.028 15302533
    [Google Scholar]
  81. MatsubaraF.H. MeissnerG.O. HerzigV. Insecticidal activity of a recombinant knottin peptide from Loxosceles intermedia venom and recognition of these peptides as a conserved family in the genus.Insect Mol. Biol.2017261253410.1111/imb.12268 27743460
    [Google Scholar]
  82. DomingosM.O. NevesI.V. VigerelliH. The potential of Loxosceles gaucho spider venom to regulate Pseudomonas aeruginosa mechanisms of virulence.Toxicon20181527883 https://repositorio.butantan.gov.br/handle/butantan/2548
    [Google Scholar]
  83. Segura-RamírezP.J. Silva JúniorP.I. Loxosceles gaucho spider venom: An untapped source of antimicrobial agents.Toxins (Basel)20181012E52210.3390/toxins10120522 30563217
    [Google Scholar]
  84. SiqueiraR.A.G.B. CalabriaP.A.L. CaporrinoM.C. When spider and snake get along: Fusion of a snake disintegrin with a spider phospholipase D to explore their synergistic effects on a tumor cell.Toxicon2019168404810.1016/j.toxicon.2019.06.225 31251993
    [Google Scholar]
  85. LauriaP.S.S. Casais-E-SilvaL.L. do Espírito-SantoR.F. Pain-like behaviors and local mechanisms involved in the nociception experimentally induced by Latrodectus curacaviensis spider venom.Toxicol. Lett.2018299677510.1016/j.toxlet.2018.09.008 30261224
    [Google Scholar]
  86. DuanZ. YanX. CaoR. LiuZ. WangX. LiangS. Proteomic analysis of Latrodectus tredecimguttatus venom for uncovering potential latrodectism-related proteins.J. Biochem. Mol. Toxicol.200822532833610.1002/jbt.20244 18972397
    [Google Scholar]
  87. QuanD. RuhaA-M. Priapism associated with Latrodectus mactans envenomation.Am. J. Emerg. Med.2009276759.e1759.e210.1016/j.ajem.2008.10.033 19751653
    [Google Scholar]
  88. Al BshabsheA. AlfaifiM. AlsayedA.F. Black widow spider bites experience from tertiary care center in Saudi Arabia.Avicenna J. Med.2017725153 28469986
    [Google Scholar]
  89. KhamtornP. RungsaP. JangprommaN. Partial proteomic analysis of brown widow spider (Latrodectus geometricus) venom to determine the biological activities.Toxicon X2020810006210.1016/j.toxcx.2020.100062 33163957
    [Google Scholar]
  90. YanS. WangX. Recent advances in research on widow spider venoms and toxins.Toxins (Basel)20157125055506710.3390/toxins7124862 26633495
    [Google Scholar]
  91. KrasnoperovV.G. ShamotienkoO.G. GrishinE.V. Isolation and properties of insect-specific neurotoxins from venoms of the spider Lactodectus mactans tredecimguttatusBioorg. Khim.199016811381140 2285428
    [Google Scholar]
  92. FesceR. SegalJ.R. CeccarelliB. HurlbutW.P. Effects of black widow spider venom and Ca2+ on quantal secretion at the frog neuromuscular junction.J. Gen. Physiol.1986881598110.1085/jgp.88.1.59 3488369
    [Google Scholar]
  93. ShaturskyO.Ya. PashkovV.N. BulgacovO.V. GrishinE.V. Interaction of alpha-latroinsectotoxin from Latrodectus mactans venom with bilayer lipid membranes.Biochim. Biophys. Acta199512331142010.1016/0005‑2736(94)00226‑F 7530491
    [Google Scholar]
  94. GrishinE.V. HimmelreichN.H. PluzhnikovK.A. Modulation of functional activities of the neurotoxin from black widow spider venom.FEBS Lett.1993336220520710.1016/0014‑5793(93)80803‑3 8262230
    [Google Scholar]
  95. Rivera-de-TorreE. Palacios-OrtegaJ. GavilanesJ.G. Martínez-Del-PozoÁ. García-LinaresS. Pore-forming proteins from cnidarians and arachnids as potential biotechnological tools.Toxins (Basel)2019116E37010.3390/toxins11060370 31242582
    [Google Scholar]
  96. MirandaA ObregoEB MejiaFR GutierrezRS Peptídeo contraceptivo derivado de veneno de aranha.BR112012024138A22017
    [Google Scholar]
  97. RomeroF. CunhaM.A. SanchezR. FerreiraA.T. SchorN. OshiroM.E.M. Effects of arachnotoxin on intracellular pH and calcium in human spermatozoa.Fertil. Steril.20078761345134910.1016/j.fertnstert.2006.11.054 17207796
    [Google Scholar]
  98. ParodiJ. NavarreteP. MarconiM. GutiérrezR.S. Martínez-TorresA. MejíasF.R. Tetraethylammonium-sensitive K(+) current in the bovine spermatozoa and its blocking by the venom of the Chilean Latrodectus mactans.Syst Biol Reprod Med2010561374310.3109/19396360903497217 20170285
    [Google Scholar]
  99. GómezP.N. AlvarezJ.G. RisopatrónJ. RomeroF. SánchezR. Effect of tubal explants and their secretions on bovine spermatozoa: Modulation of ROS production and DNA damage.Reprod. Fertil. Dev.201224687187610.1071/RD11180 22781938
    [Google Scholar]
  100. GómezP.N. AlvarezJ.G. ParodiJ. RomeroF. SánchezR. Effect of aracnotoxin from Latrodectus mactans on bovine sperm function: Modulatory action of bovine oviduct cells and their secretions.Andrologia201244Suppl. 176477110.1111/j.1439‑0272.2011.01263.x 22211875
    [Google Scholar]
  101. MesngonM. McNuttP. Alpha-latrotoxin rescues SNAP-25 from BoNT/A-mediated proteolysis in embryonic stem cell-derived neurons.Toxins (Basel)20113548950310.3390/toxins3050489 22069721
    [Google Scholar]
  102. DuregottiE. ZanettiG. ScorzetoM. Snake and spider toxins induce a rapid recovery of function of botulinum neurotoxin paralysed neuromuscular junction.Toxins (Basel)20157125322533610.3390/toxins7124887 26670253
    [Google Scholar]
  103. HolzG.G. LeechC.A. HabenerJ.F. Insulinotropic toxins as molecular probes for analysis of glucagon-likepeptide-1 receptor-mediated signal transduction in pancreatic beta-cells.Biochimie2000829-1091592610.1016/S0300‑9084(00)01171‑8 11086221
    [Google Scholar]
  104. WangX. TangX. XuD. YuD. Molecular basis and mechanism underlying the insecticidal activity of venoms and toxins from Latrodectus spiders.Pest Manag. Sci.201975231832310.1002/ps.5206 30204933
    [Google Scholar]
  105. LeiQ. YuH. PengX. Isolation and preliminary characterization of proteinaceous toxins with insecticidal and antibacterial activities from black widow spider (L. tredecimguttatus) eggs.Toxins (Basel)20157388689910.3390/toxins7030886 25785465
    [Google Scholar]
  106. PengX. ZhangY. LiuJ. Physiological and biochemical analysis to reveal the molecular basis for black widow spiderling toxicity.J. Biochem. Mol. Toxicol.201428519820510.1002/jbt.21553 24616210
    [Google Scholar]
  107. MakoverV. RonenZ. LubinY. KhalailaI. Eggshell spheres protect brown widow spider (Latrodectus geometricus) eggs from bacterial infection.J. R. Soc. Interface2019161502018058110.1098/rsif.2018.0581 30958158
    [Google Scholar]
  108. XuD. TangX. WuX. YuD. TangP. WangX. Anti-breast cancer activity of latroeggtoxin-v mined from the transcriptome of spider Latrodectus tredecimguttatus eggs.Toxins (Basel)20181011E45110.3390/toxins10110451 30400202
    [Google Scholar]
  109. PengX. DaiZ. LeiQ. LiangL. YanS. WangX. Cytotoxic and apoptotic activities of black widow spiderling extract against HeLa cells.Exp. Ther. Med.20171363267327410.3892/etm.2017.4391 28587399
    [Google Scholar]
  110. AhmadiS. KnerrJ.M. ArgemiL. Scorpion venom: Detriments and benefits.Biomedicines20208511810.3390/biomedicines8050118 32408604
    [Google Scholar]
  111. ColognaC.T. MarcussiS. GiglioJ.R. SoaresA.M. ArantesE.C. Tityus serrulatus scorpion venom and toxins: An overview.Protein Pept. Lett.200916892093210.2174/092986609788923329 19689419
    [Google Scholar]
  112. AlvarengaE.R. MendesT.M. MagalhaesB.F. Transcriptome analysis of the Tityus serrulatus scorpion venom gland.Open J. Genet.2012020421022010.4236/ojgen.2012.24027
    [Google Scholar]
  113. FajlounZ. MosbahA. CarlierE. Maurotoxin versus Pi1/HsTx1 scorpion toxins. Toward new insights in the understanding of their distinct disulfide bridge patterns.J. Biol. Chem.200027550393943940210.1074/jbc.M006810200 10970898
    [Google Scholar]
  114. Oliveira-MendesB.B.R. MirandaS.E.M. Sales-MedinaD.F. Inhibition of Tityus serrulatus venom hyaluronidase affects venom biodistribution.PLoS Negl. Trop. Dis.2019134e000704810.1371/journal.pntd.0007048 31002673
    [Google Scholar]
  115. CarmoA.O. Oliveira-MendesB.B.R. HortaC.C.R. Molecular and functional characterization of metalloserrulases, new metalloproteases from the Tityus serrulatus venom gland.Toxicon201490455510.1016/j.toxicon.2014.07.014 25091350
    [Google Scholar]
  116. PimentaAMDC Perez-GarciaME de L DinizCR SantosRAS BougisPE Martin-EauclaireM-F Peptìdeo obtido de veneno escorpião para uso como agente hipotensivo.BR0202157A2005
  117. BragaTV PimentaAMC Perez-GarciaMEDL SantosRAS DinizCR Martin-EauclaireM-F Modificação, redução da estrutura primária e sìntese de peptìdeos hipotensivos presentes no veneno de escorpião para otimização na utilização dos mesmos como fármacos.BRPI0801542A22009
    [Google Scholar]
  118. MendesLDG Junior, Pedrosa MDFF, Araújo RJ, Braga VA. Síntese de peptídeo hipotensivo com estrutura primária reduzida presente no veneno do escorpião tityus stigmurus para otimização e utilização como fármaco.BR102014018478A22017
  119. CarmoAO DantasAE Oliveira-MendesBBR Peptídeo carreador para entrega intracitoplasmática e intranuclear de moléculas e uso.BR102015008331A22017
    [Google Scholar]
  120. Oliveira-MendesB.B.R. HortaC.C.R. do CarmoA.O. CPP-Ts: A new intracellular calcium channel modulator and a promising tool for drug delivery in cancer cells.Sci. Rep.2018811473910.1038/s41598‑018‑33133‑3 30282983
    [Google Scholar]
  121. De WaardM. Small efficient cell penetrating peptides derived from the scorpion toxin maurocalcine.WO2012176138A22012
    [Google Scholar]
  122. FletcherMD FletcherPL MartinBM Fast acting snare-cleaving enzymes. WO2011022357A22011
    [Google Scholar]
  123. RigoF.K. BochiG.V. PereiraA.L. TsNTxP, a non-toxic protein from Tityus serrulatus scorpion venom, induces antinociceptive effects by suppressing glutamate release in mice.Eur. J. Pharmacol.2019855657410.1016/j.ejphar.2019.05.002 31059709
    [Google Scholar]
  124. de MeloE.T. EstrelaA.B. SantosE.C.G. Structural characterization of a novel peptide with antimicrobial activity from the venom gland of the scorpion Tityus stigmurus: Stigmurin.Peptides20156831010.1016/j.peptides.2015.03.003 25805002
    [Google Scholar]
  125. ParenteA.M.S. Daniele-SilvaA. FurtadoA.A. Analogs of the scorpion venom peptide stigmurin: Structural assessment, toxicity, and increased antimicrobial activity.Toxins (Basel)2018104E16110.3390/toxins10040161 29670004
    [Google Scholar]
  126. de Jesus OliveiraT. OliveiraU.C. da SilvaJunior P.I. Serrulin: A glycine-rich bioactive peptide from the hemolymph of the yellow Tityus serrulatus scorpion.Toxins (Basel)201911951710.3390/toxins11090517 31489876
    [Google Scholar]
  127. Marques-NetoLM TrentiniMM das NevesRC Antimicrobial and Chemotactic Activity of Scorpion-Derived Peptide, ToAP2, against Mycobacterium massiliensis.Toxins (Basel)2018106E21910.3390/toxins10060219 29848960
    [Google Scholar]
  128. FreitasSM PereiraIS MortariMR NicolaPAA SchwartzENF CostaFG Peptídeo antimicrobiano, seu processo de obtenção e uso. BR102017024728A22020
    [Google Scholar]
  129. GuilhelmelliF. VilelaN. SmidtK.S. Activity of scorpion venom-derived antifungal peptides against planktonic cells of Candida spp. and Cryptococcus neoformans and Candida albicans biofilms.Front Microbiol201671844http://journal.frontiersin.org/article/10.3389/fmicb.2016.01844/full10.3389/fmicb.2016.01844 27917162
    [Google Scholar]
  130. SchwartzENF MourãoCBF JoanittiGA BrandGD BarbosaJARG FernandesJPC Peptídeos inibidores de serinopeptidase modificados de peçonha de escorpião, seu processo de obtenção e uso. BR102017013362A22020
  131. BordonK.C.F. WiezelG.A. AmorimF.G. ArantesE.C. Arthropod venom Hyaluronidases: Biochemical properties and potential applications in medicine and biotechnology.J. Venom. Anim. Toxins Incl. Trop. Dis.20152114310.1186/s40409‑015‑0042‑7 26500679
    [Google Scholar]
  132. Guerra-DuarteC. Rebello HortaC.C. Ribeiro Oliveira-MendesB.B. Determination of hyaluronidase activity in Tityus spp. Scorpion venoms and its inhibition by Brazilian antivenoms.Toxicon201916713414310.1016/j.toxicon.2019.06.019 31207348
    [Google Scholar]
  133. LeeJ.A. SonM.J. ChoiJ. YunK-J. JunJ.H. LeeM.S. Bee venom acupuncture for rheumatoid arthritis: A systematic review protocol.BMJ Open201444e00460210.1136/bmjopen‑2013‑004602 24760349
    [Google Scholar]
  134. MorenoM. GiraltE. Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: Melittin, apamin and mastoparan.Toxins (Basel)2015741126115010.3390/toxins7041126 25835385
    [Google Scholar]
  135. KunitzA.G. Melitina proveniente do veneno de abelha: Processo de purificação, aplicação e avaliação econômica.Universidade Federal de Santa Catarina2015
    [Google Scholar]
  136. AlvesEM CoelhoMDM HeneineLGD MerloLDA PesqueroJL Processo de produção de bioprodutos elaborados com componentes isolados de apitoxina de abelhas Apis mellifera, composição e uso.BRPI0904036A22011
  137. VickJ.A. MehlmanB. BrooksR. PhillipsS.J. ShipmanW. Effect of the bee venom and melittin on plasma cortisol in the unanesthetized monkey.Toxicon197210658158610.1016/0041‑0101(72)90119‑5 4198739
    [Google Scholar]
  138. VickJ.A. ShipmanW.H. Effects of whole bee venom and its fractions (apamin and melittin) on plasma cortisol levels in the dog.Toxicon197210437738010.1016/0041‑0101(72)90061‑X 5070576
    [Google Scholar]
  139. RekkaE. KourounakisL. KourounakisP. Antioxidant activity of and interleukin production affected by honey bee venom.Arzneimittelforschung1990408912913 2242083
    [Google Scholar]
  140. NamK-W. JeK-H. LeeJ.H. Inhibition of COX-2 activity and proinflammatory cytokines (TNF-alpha and IL-1beta) production by water-soluble sub-fractionated parts from bee (Apis mellifera) venom.Arch. Pharm. Res.200326538338810.1007/BF02976695 12785734
    [Google Scholar]
  141. JangH-S. KimS.K. HanJ-B. AhnH-J. BaeH. MinB-I. Effects of bee venom on the pro-inflammatory responses in RAW264.7 macrophage cell line.J. Ethnopharmacol.200599115716010.1016/j.jep.2005.02.026 15848037
    [Google Scholar]
  142. KimH. ParkS-Y. LeeG. Potential therapeutic applications of bee venom on skin disease and its mechanisms: A literature review.Toxins (Basel)2019117E37410.3390/toxins11070374 31252651
    [Google Scholar]
  143. HanS. LeeK. YeoJ. BaekH. ParkK. Antibacterial and anti-inflammatory effects of honeybee (Apis mellifera) venom against acne-inducing bacteria.J. Med. Plants Res.201046459464
    [Google Scholar]
  144. Kurek-GóreckaA. GóreckiM. Rzepecka-StojkoA. BalwierzR. StojkoJ. Bee products in dermatology and skin care.Molecules202025355610.3390/molecules25030556 32012913
    [Google Scholar]
  145. TuW-C. WuC-C. HsiehH-L. ChenC-Y. HsuS-L. Honeybee venom induces calcium-dependent but caspase-independent apoptotic cell death in human melanoma A2058 cells.Toxicon200852231832910.1016/j.toxicon.2008.06.007 18602939
    [Google Scholar]
  146. HanS.M. HongI.P. WooS.O. The beneficial effects of honeybee-venom serum on facial wrinkles in humans.Clin. Interv. Aging2015101587159210.2147/CIA.S84940 26491274
    [Google Scholar]
  147. WatalaC. Gwoździński K. Melittin-induced alterations in dynamic properties of human red blood cell membranes.Chem. Biol. Interact.199282213514910.1016/0009‑2797(92)90106‑U 1314707
    [Google Scholar]
  148. CeremugaM. StelaM. JanikE. Melittin-A natural peptide from bee venom which induces apoptosis in human leukaemia cells.Biomolecules202010224710.3390/biom10020247 32041197
    [Google Scholar]
  149. RadyI. SiddiquiI.A. RadyM. MukhtarH. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy.Cancer Lett.2017402163110.1016/j.canlet.2017.05.010 28536009
    [Google Scholar]
  150. ZhangS-F. ChenZ. Melittin exerts an antitumor effect on non small cell lung cancer cells.Mol. Med. Rep.20171633581358610.3892/mmr.2017.6970 28713976
    [Google Scholar]
  151. HongJ. LuX. DengZ. XiaoS. YuanB. YangK. How Melittin Inserts into Cell Membrane: Conformational changes, inter-peptide cooperation, and disturbance on the membrane. Molecules2019249E1775https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539814/10.3390/molecules24091775 31067828
  152. Oller-SalviaB. Sánchez-NavarroM. GiraltE. TeixidóM. Blood-brain barrier shuttle peptides: An emerging paradigm for brain delivery.Chem. Soc. Rev.201645174690470710.1039/C6CS00076B 27188322
    [Google Scholar]
  153. WillisM. TriebM. LeitnerI. WietzorrekG. MarksteinerJ. KnausH-G. Small-conductance calcium-activated potassium type 2 channels (SK2, KCa2.2) in human brain.Brain Struct. Funct.2017222297397910.1007/s00429‑016‑1258‑1 27357310
    [Google Scholar]
  154. PatelD. KuyucakS. DoupnikC.A. Structural determinants mediating tertiapin block of neuronal kir3.2 channels.Biochemistry202059783685010.1021/acs.biochem.9b01098 31990535
    [Google Scholar]
  155. GongJ. YuanH. GaoZ. HuF. Wasp venom and acute kidney injury: The mechanisms and therapeutic role of renal replacement therapy.Toxicon20191631710.1016/j.toxicon.2019.03.008 30880185
    [Google Scholar]
  156. MullerJ.A.I. MoslavesI.S.B. OliveiraE.J.T. Pro-inflammatory response induced by the venom of Parachartergus fraternus wasp.Toxicon Off J Int Soc Toxinol2021190111910.1016/j.toxicon.2020.11.176 33290790
    [Google Scholar]
  157. MullerJ.A.I. LencinaJ.S. SouzaM.I.L. MortariM.R. Toffoli-KadriM.C. Macrophage activation in vitro by Parachartergus fraternus venom.Toxicon2021198485310.1016/j.toxicon.2021.04.028
    [Google Scholar]
  158. PfeifferD.R. GudzT.I. NovgorodovS.A. ErdahlW.L. The peptide mastoparan is a potent facilitator of the mitochondrial permeability transition.J. Biol. Chem.199527094923493210.1074/jbc.270.9.4923 7876267
    [Google Scholar]
  159. Dos Santos-PintoJ.R.A. Perez-RiverolA. LasaA.M. PalmaM.S. Diversity of peptidic and proteinaceous toxins from social Hymenoptera venoms.Toxicon201814817219610.1016/j.toxicon.2018.04.029 29715467
    [Google Scholar]
  160. SilvaJ.C. NetoL.M. NevesR.C. Evaluation of the antimicrobial activity of the mastoparan Polybia-MPII isolated from venom of the social wasp Pseudopolybia vespiceps testacea (Vespidae, Hymenoptera).Int. J. Antimicrob. Agents201749216717510.1016/j.ijantimicag.2016.11.013 28108242
    [Google Scholar]
  161. BiolchiA.M. de OliveiraD.G.R. AmaralH.O. Fraternine, a novel wasp peptide, protects against motor impairments in 6-OHDA model of parkinsonism.Toxins (Basel)2020129E55010.3390/toxins12090550 32867207
    [Google Scholar]
  162. GomesF.M.M. PaniagoC.K. FreireD.O. Anxiolytic-like effect of a novel peptide isolated from the venom of the social wasp Synoeca surinama.Toxicon Off J Int Soc Toxinology2016122394210.1016/j.toxicon.2016.09.015 27664832
    [Google Scholar]
  163. do CoutoL.L. Dos AnjosL.C. AraujoM de AF. Anticonvulsant and anxiolytic activity of the peptide fraction isolated from the venom of the social wasp Polybia paulista.Pharmacogn. Mag.201283229229910.4103/0973‑1296.103657 24082633
    [Google Scholar]
  164. DouradoL.F.N. SilvaC.N. Dos AnjosL.C. MortariM.R. Silva-CunhaA. FialhoS.L. Ischemia-induced retinal injury is attenuated by Neurovespina, a peptide from the venom of the social wasp Polybia occidentalis.Neuropeptides20218510211310.1016/j.npep.2020.102113 33370615
    [Google Scholar]
  165. MortariM.R. CunhaA.O.S. de OliveiraL. Anticonvulsant and behavioural effects of the denatured venom of the social wasp Polybia occidentalis (Polistinae, Vespidae).Basic Clin. Pharmacol. Toxicol.200597528929510.1111/j.1742‑7843.2005.pto_137.x 16236140
    [Google Scholar]
  166. CunhaA.O.S. MortariM.R. OliveiraL. CarolinoR.O.G. Coutinho-NettoJ. dos SantosW.F. Anticonvulsant effects of the wasp Polybia ignobilis venom on chemically induced seizures and action on GABA and glutamate receptors.Comp. Biochem. Physiol. C Toxicol. Pharmacol.20051411505710.1016/j.cca.2005.05.004 15953769
    [Google Scholar]
  167. LopesK.S. QuintanilhaM.V.T. de SouzaA.C.B. Zamudio-ZuñigaF. PossaniL.D. MortariM.R. Antiseizure potential of peptides from the venom of social wasp Chartergellus communis against chemically-induced seizures.Toxicon Off J Int Soc Toxinology2021194233610.1016/j.toxicon.2021.02.009 33610635
    [Google Scholar]
  168. MortariM.R. CunhaA.O.S. CarolinoR.O.G. Inhibition of acute nociceptive responses in rats after i.c.v. injection of Thr6-bradykinin, isolated from the venom of the social wasp, Polybia occidentalis.Br. J. Pharmacol.2007151686086910.1038/sj.bjp.0707275 17533426
    [Google Scholar]
  169. MortariMR CarneiroLDA Peptídeo modificado da peçonha de vespa social e seu uso como antiepiléptico e neuroprotetor.BR102014004728A22016
    [Google Scholar]
  170. MortariMR MayerAB SouzaACB FernandesSCR AmaralHO LimaMR Peptídeos modificados da peçonha da vespa social Parachartergus fraternus e seu uso no tratamento de doenças neurodegenerativas.BR102018008420A22020
  171. MortariMR SchwartzENF GonçalvesJC RibeiroPG SilvaLP Peptídeo modificado de peçonha de vespa social e seu uso como analgésico.BR102014020510A22016
    [Google Scholar]
  172. SeldeslachtsA. PeigneurS. TytgatJ. Caterpillar venom: A health hazard of the 21st century.Biomedicines202086E14310.3390/biomedicines8060143 32486237
    [Google Scholar]
  173. Chudzinski-TavassiAM Alvarez FloresMP Exploring new molecules and activities from Lonomia obliqua caterpillars - abstract - pathophysiology of haemostasis and thrombosis Karger Publishers 20053445https://www.karger.com/Article/Abstract/92429
    [Google Scholar]
  174. ReisC.V. FarskyS.H. FernandesB.L. In vivo characterization of Lopap, a prothrombin activator serine protease from the Lonomia obliqua caterpillar venom.Thromb. Res.2001102543744310.1016/S0049‑3848(01)00268‑7 11395129
    [Google Scholar]
  175. Chudzinski-TavassiAM ReisCV Processo de purificação de proteìnas solúveis das cerdas da l. oblìqua com atividade ativadora de protrombina; processo para determinação parcial da sequência de aminoácidos do ativador de protrombina; processo de determinação da atividade ativadora de protrombina da fração ii, sequência n-terminal e sequência de fragmentos internos da fração ativadora de protrombina, ativador de protrombina e uso do ativador de protrombina.BR0200269A2004
    [Google Scholar]
  176. Chudzinski-TavassiAM FarskyS FritzenM HoPL RamosCR ReisCV Processo de obtenção de protease ativadora de protrombina recombinate (lopap) na forma monomérica; protease ativadora de protrombina recombinate (lopap), seqüência de aminoácidos da proteìna recombinante assim obtida e uso como agente desfibrinogenante e kit diagnóstico para desprotrombinemias.BRPI0403882A2006
  177. Chudzinski-Tavassi AM, Falci M, Maria DA, Reis CV. Composições farmacêuticas baseadas em lopap e usos das ditas composições.BRPI0504199A2007
/content/journals/vat/10.2174/2666121702666220523143235
Loading
/content/journals/vat/10.2174/2666121702666220523143235
Loading

Data & Media loading...


  • Article Type:
    Review Article
Keyword(s): arthropod; biotechnological potential; brazil; Patent; toxin; venom
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test